Pharma And Biotech CRM Software Global Market Opportunities And Strategies To 2034

Published Jul 09, 2025

Length 330 Pages

SKU # BRC20178156

Description

Pharma And Biotech CRM Software Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pharma and biotech CRM software market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:

Where is the largest and fastest-growing market for pharma and biotech CRM software? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The pharma and biotech CRM software market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider pharma and biotech CRM software market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technology, by deployment, by enterprise size and by industry.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by technology, by deployment, by enterprise size and by industry in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Recent Developments- Information on recent developments in the market covered in the report.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for pharma and biotech CRM software providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Technology: Artificial Intelligence Customer Relationship Management (CRM); Conventional Customer Relationship Management (CRM)

2) By Deployment: On-Premise; Cloud-Based

3) By Enterprise Size: Large Enterprises; Small And Medium Enterprises (SMEs)

4) By Industry: Pharmaceuticals; Biotech

Companies Mentioned: Veeva Systems Inc.; IQVIA Holdings Inc.; Salesforce.com Inc.; Oracle Corporation; SAP SE

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; pharma and biotech CRM software indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1 Executive Summary: 1.1 Pharma And Biotech CRM Software – Market Attractiveness And Macro Economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics: 6.1 General Market Definition; 6.2 Summary; 6.3 Pharma And Biotech CRM Software Market Definition And Segmentations; 6.4 Market Segmentation By Technology; 6.4.1 Artificial Intelligence Customer Relationship Management (CRM); 6.4.2 Conventional Customer Relationship Management (CRM); 6.5 Market Segmentation By Deployment; 6.5.1 On-Premises; 6.5.2 Cloud-Based; 6.6 Market Segmentation By Enterprise Size; 6.6.1 Large Enterprises; 6.6.2 Small And Medium Enterprises (SMEs); 6.7 Market Segmentation By Industry; 6.7.1 Pharmaceuticals; 6.7.2 Biotech
7 Major Market Trends: 7.1 Integrating Electronic Health Records Into Pharma CRM Systems; 7.2 Strategic Partnerships Driving Innovation In Pharma And Biotech CRM Software; 7.3 Voice-Controlled CRM Interfaces Boosting Productivity In Pharma Sales
8 Global Pharma And Biotech CRM Software Growth Analysis And Strategic Analysis Framework: 8.1 Global: PESTEL Analysis; 8.1.1 Political; 8.1.2 Economic; 8.1.3 Social; 8.1.4 Technological; 8.1.5 Environmental; 8.1.6 Legal; 8.2 End Users of B2B Market; 8.2.1 Pharmaceutical Companies; 8.2.2 Biotechnology Companies; 8.3 Global Market Size and Growth; 8.4 Historic Market Growth, 2019 – 2024, Value ($ Million); 8.4.1 Market Drivers 2019 – 2024; 8.4.2 Market Restraints 2019 – 2024; 8.5 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million); 8.6 Forecast Growth Contributors/Factors; 8.6.1 Quantitative Growth Contributors; 8.6.2 Drivers; 8.6.3 Restraints; 8.7 Global Pharma And Biotech CRM Software Total Addressable Market (TAM)
9 Global Pharma And Biotech CRM Software Market Segmentation: 9.1 Global Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.2 Global Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.3 Global Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.4 Global Pharma And Biotech CRM Software Market, Segmentation By Industry, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.5 Global Pharma And Biotech CRM Software Market, Sub-Segmentation Of Artificial Intelligence Customer Relationship Management (CRM), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, Value ($ Million); 9.6 Global Pharma And Biotech CRM Software Market, Sub-Segmentation Of Conventional Customer Relationship Management (CRM), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, Value ($ Million)
10 Pharma And Biotech CRM Software Market, Regional and Country Analysis: 10.1 Global Pharma And Biotech CRM Software Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 10.2 Global Pharma And Biotech CRM Software Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11 Asia-Pacific Market: 11.1 Summary; 11.2 Market Overview; 11.2.1 Region Information; 11.2.2 Market Information; 11.2.3 Background Information; 11.2.4 Government Initiatives; 11.2.5 Regulations; 11.2.6 Regulatory Bodies; 11.2.7 Major Associations; 11.2.8 Taxes Levied; 11.2.9 Corporate Tax Structure; 11.2.10 Investments; 11.2.11 Major Companies; 11.3 Asia Pacific Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.4 Asia Pacific Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.5 Asia Pacific Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.6 Asia-Pacific Pharma And Biotech CRM Software Market: Country Analysis; 11.7 China Market; 11.8 Summary; 11.9 Market Overview; 11.9.1 Country Information; 11.9.2 Market Information; 11.9.3 Background Information; 11.9.4 Government Initiatives; 11.9.5 Regulations; 11.9.6 Regulatory Bodies; 11.9.7 Major Associations; 11.9.8 Taxes Levied; 11.9.9 Corporate Tax Structure; 11.9.10 Investments; 11.9.11 Major Companies; 11.10 China Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.11 China Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.12 China Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.13 India Market; 11.14 India Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.15 India Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.16 India Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.17 Japan Market; 11.18 Summary; 11.19 Market Overview; 11.19.1 Country Information; 11.19.2 Market Information; 11.19.3 Background Information; 11.19.4 Government Initiatives; 11.19.5 Regulations; 11.19.6 Regulatory Bodies; 11.19.7 Major Associations; 11.19.8 Taxes Levied; 11.19.9 Corporate Tax Structure; 11.19.10 Investments; 11.19.11 Major Companies; 11.20 Japan Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.21 Japan Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.22 Japan Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.23 Australia Market; 11.24 Australia Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.25 Australia Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.26 Australia Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.27 Indonesia Market; 11.28 Indonesia Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.29 Indonesia Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.30 Indonesia Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.31 South Korea Market; 11.32 Summary; 11.33 Market Overview; 11.33.1 Country Information; 11.33.2 Market Information; 11.33.3 Background Information; 11.33.4 Government Initiatives; 11.33.5 Regulations; 11.33.6 Regulatory Bodies; 11.33.7 Major Associations; 11.33.8 Taxes Levied; 11.33.9 Corporate Tax Structure; 11.33.10 Investments; 11.33.11 Major Companies; 11.34 South Korea Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.35 South Korea Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.36 South Korea Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12 Western Europe Market: 12.1 Summary; 12.2 Market Overview; 12.2.1 Region Information; 12.2.2 Market Information; 12.2.3 Background Information; 12.2.4 Government Initiatives; 12.2.5 Regulations; 12.2.6 Regulatory Bodies; 12.2.7 Major Associations; 12.2.8 Taxes Levied; 12.2.9 Corporate tax structure; 12.2.10 Investments; 12.2.11 Major Companies; 12.3 Western Europe Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.4 Western Europe Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.5 Western Europe Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.6 Western Europe Pharma And Biotech CRM Software Market: Country Analysis; 12.7 UK Market; 12.8 UK Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.9 UK Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.10 UK Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.11 Germany Market; 12.12 Germany Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.13 Germany Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.14 Germany Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.15 France Market; 12.16 France Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.17 France Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.18 France Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.19 Italy Market; 12.20 Italy Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.21 Italy Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.22 Italy Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.23 Spain Market; 12.24 Spain Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.25 Spain Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.26 Spain Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13 Eastern Europe Market: 13.1 Summary; 13.2 Market Overview; 13.2.1 Region Information; 13.2.2 Market Information; 13.2.3 Background Information; 13.2.4 Government Initiatives; 13.2.5 Regulations; 13.2.6 Regulatory Bodies; 13.2.7 Major Associations; 13.2.8 Taxes Levied; 13.2.9 Corporate Tax Structure; 13.2.10 Major companies; 13.3 Eastern Europe Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.4 Eastern Europe Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.5 Eastern Europe Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.6 Eastern Europe Pharma And Biotech CRM Software Market: Country Analysis; 13.7 Russia Market; 13.8 Russia Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.9 Russia Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.10 Russia Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14 North America Market: 14.1 Summary; 14.2 Market Overview; 14.2.1 Region Information; 14.2.2 Market Information; 14.2.3 Background Information; 14.2.4 Government Initiatives; 14.2.5 Regulations; 14.2.6 Regulatory Bodies; 14.2.7 Major Associations; 14.2.8 Taxes Levied; 14.2.9 Corporate Tax Structure; 14.2.10 Investments; 14.2.11 Major Companies; 14.3 North America Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.4 North America Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.5 North America Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.6 North America Pharma And Biotech CRM Software Market: Country Analysis; 14.7 USA Market; 14.8 Summary; 14.9 Market Overview; 14.9.1 Country Information; 14.9.2 Market Information; 14.9.3 Background Information; 14.9.4 Government Initiatives; 14.9.5 Regulations; 14.9.6 Regulatory Bodies; 14.9.7 Major Associations; 14.9.8 Taxes Levied; 14.9.9 Corporate Tax Structure; 14.9.10 Investments; 14.9.11 Major Companies; 14.10 USA Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.11 USA Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.12 USA Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.13 Canada Market; 14.14 Summary; 14.15 Market Overview; 14.15.1 Region Information; 14.15.2 Market Information; 14.15.3 Background Information; 14.15.4 Government Initiatives; 14.15.5 Regulations; 14.15.6 Regulatory Bodies; 14.15.7 Major Associations; 14.15.8 Taxes Levied; 14.15.9 Corporate Tax Structure; 14.15.10 Investments; 14.15.11 Major Companies; 14.16 Canada Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.17 Canada Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.18 Canada Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15 South America Market: 15.1 Summary; 15.2 Market Overview; 15.2.1 Region Information; 15.2.2 Market Information; 15.2.3 Background Information; 15.2.4 Government Initiatives; 15.2.5 Regulations; 15.2.6 Regulatory Bodies; 15.2.7 Major Associations; 15.2.8 Taxes Levied; 15.2.9 Corporate Tax Structure; 15.2.10 Major Companies; 15.3 South America Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.4 South America Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.5 South America Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.6 South America Pharma And Biotech CRM Software Market: Country Analysis; 15.7 Brazil Market; 15.8 Brazil Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.9 Brazil Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.10 Brazil Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16 Middle East Market: 16.1 Summary; 16.2 Market Overview; 16.2.1 Region Information; 16.2.2 Market Information; 16.2.3 Background Information; 16.2.4 Government Initiatives; 16.2.5 Regulations; 16.2.6 Regulatory Bodies; 16.2.7 Major Associations; 16.2.8 Taxes Levied; 16.2.9 Corporate Tax Structure; 16.2.10 Major Companies; 16.3 Middle East Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 16.4 Middle East Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 16.5 Middle East Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17 Africa Market: 17.1 Summary; 17.2 Market Overview; 17.2.1 Region Information; 17.2.2 Market Information; 17.2.3 Background Information; 17.2.4 Government Initiatives; 17.2.5 Regulations; 17.2.6 Regulatory Bodies; 17.2.7 Major Associations; 17.2.8 Taxes Levied; 17.2.9 Corporate Tax Structure; 17.2.10 Major Companies; 17.3 Africa Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 17.4 Africa Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 17.5 Africa Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
18 Competitive Landscape And Company Profiles: 18.1 Company Profiles; 18.2 Veeva Systems Inc; 18.2.1 Company Overview; 18.2.2 Products And Services; 18.2.3 Business Strategy; 18.2.4 Financial Overview; 18.3 IQVIA Holdings Inc; 18.3.1 Company Overview; 18.3.2 Products And Services; 18.3.3 Business Strategy; 18.3.4 Financial Overview; 18.4 Salesforce Inc; 18.4.1 Company Overview; 18.4.2 Products And Services; 18.4.3 Business Strategy; 18.4.4 Financial Overview; 18.5 Oracle Corporation; 18.5.1 Company Overview; 18.5.2 Products And Services; 18.5.3 Business Strategy; 18.5.4 Financial Overview; 18.6 SAP SE; 18.6.1 Company Overview; 18.6.2 Products And Services; 18.6.3 Financial Overview
19 Other Major And Innovative Companies: 19.1 Microsoft Corporation; 19.1.1 Company Overview; 19.1.2 Products And Services; 19.2 Zoho Corporation Pvt. Ltd.; 19.2.1 Company Overview; 19.2.2 Products And Services; 19.3 Pega Systems Inc.; 19.3.1 Company Overview; 19.3.2 Products And Services; 19.4 HubSpot Inc.; 19.4.1 Company Overview; 19.4.2 Products And Services; 19.5 Indegene Private Limited; 19.5.1 Company Overview; 19.5.2 Products And Services; 19.6 Aurea Software Inc.; 19.6.1 Company Overview; 19.6.2 Products And Services; 19.7 Axtria Inc.; 19.7.1 Company Overview; 19.7.2 Products And Services; 19.8 Pipedrive Inc.; 19.8.1 Company Overview; 19.8.2 Products And Services; 19.9 Syneos Health Inc.; 19.9.1 Company Overview; 19.9.2 Products And Services; 19.10 Close-Up International Limited; 19.10.1 Company Overview; 19.10.2 Products And Services; 19.11 CRMNEXT Pharmaceutical; 19.11.1 Company Overview; 19.11.2 Products And Services; 19.12 SugarCRM Inc.; 19.12.1 Company Overview; 19.12.2 Products And Services; 19.13 Creatio (formerly bpm’online); 19.13.1 Company Overview; 19.13.2 Products And Services; 19.14 StayinFront Inc.; 19.14.1 Company Overview; 19.14.2 Products And Services; 19.15 Synergistix Inc.; 19.15.1 Company Overview; 19.15.2 Products And Services
20 Competitive Benchmarking
21 Competitive Dashboard
22 Key Mergers And Acquisitions: 22.1 Valsoft Acquired Exeevo; 22.2 Zensar Technologies Acquired BridgeView Life Sciences; 22.3 Nomadia Acquired Nomadvantage; 22.4 Aktana Acquired Tact.ai
23 Recent Developments In Pharma And Biotech CRM Software Market: 23.1 Expansion Of AI-Powered, Region-Specific CRM Solutions In Emerging Markets; 23.2 AI-Powered Healthcare Assistant Streamlines Clinical Workflows
24 Opportunities And Strategies: 24.1 Global Pharma And Biotech CRM Software Market In 2029 – Countries Offering Most New Opportunities; 24.2 Global Pharma And Biotech CRM Software Market In 2029 – Segments Offering Most New Opportunities; 24.3 Global Pharma And Biotech CRM Software Market In 2029 – Growth Strategies; 24.3.1 Market Trend Based Strategies; 24.3.2 Competitor Strategies
25 Pharma And Biotech CRM Software Market, Conclusions And Recommendations: 25.1 Conclusions; 25.2 Recommendations; 25.2.1 Product; 25.2.2 Place; 25.2.3 Price; 25.2.4 Promotion; 25.2.5 People
26 Appendix: 26.1 Geographies Covered; 26.2 Market Data Sources; 26.3 Research Methodology; 26.4 Currencies; 26.5 The Business Research Company; 26.6 Copyright and Disclaimer

Search Inside Report

Pricing

Currency Rates

Single User Online Download $4,490
Site License Online Download $6,490
Global Site License Online Download $8,490

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now